Hints and tips:
...Qiagen needed a two-thirds majority. On Thursday, it said it had only secured just under half....
...It raises questions over whether Qiagen’s board can continue to stay in place, given its support for the transaction....
...Qiagen and Thermo Fisher did not immediately respond to requests to comment. Since the deal was announced, Qiagen’s stock price has increased by almost 25 per cent....
...In a letter to Qiagen’s board, Davidson Kempner said the revised offer was a “step in the right direction.”...
...Thermo Fisher will pay €39 a share for Qiagen, valuing the group at $11.5bn, including $1.4bn in debt. The offer represents a 23 per cent premium to Qiagen’s closing share price on Monday....
...Davidson Kempner has been building a stake in Qiagen — it’s now the second-largest shareholder with 8 per cent — while arguing against Thermo Fisher’s offer....
...It wasn’t an IPO or bond offering, but rather the $11.5bn takeover of Qiagen by Thermo Fisher....
...The commitments by German-based Qiagen and MSD, the company known as Merck in North America, come as ministers publish an industrial strategy intended to reassure business about the UK’s prospects as it...
...Try our weekly FirstFT quiz Meredith Corporation has teamed up with the billionaire Koch brothers to acquire Time Inc, which publishes Time, People and Sports Illustrated magazines....
...Other developers of companion diagnostics include Abbott Laboratories, Agilent Technologies, Myriad Genetics and Qiagen....
...Digene jumped 26.9 per cent to $56.82 after Qiagen said it would buy the diagnostic healthcare company for $1.6bn in cash and stock. Qiagen fell 9.8 per cent to $15.58....
...Digene jumped 25.6 per cent to $56.25 this week after Qiagen said it would buy the diagnostic healthcare company for $1.6bn in cash and stock. Qiagen fell 5.2 per cent to $16.38....
International Edition